Dave Ferrera
Direttore/Membro del Consiglio presso Singlepass, Inc.
Profilo
Dave Ferrera was the founder of Blockade Medical LLC, which was founded in 2011, where he held the title of President & Chief Technology Officer.
Currently, he is a Director at Singlepass, Inc.
Posizioni attive di Dave Ferrera
| Società | Posizione | Inizio |
|---|---|---|
Singlepass, Inc.
 Singlepass, Inc. Medical SpecialtiesHealth Technology Singlepass, Inc. has developed a unique electrocautery device that improves the clinical outcomes of deep tissue biopsy procedures. The company is based in Lake Forest, CA. The patented, single-use device prevents and stops bleeding caused by tissue extraction by cauterizing the tissue channel. It is the only cautery device of its kind that can be used for biopsy procedures. Singlepass was founded by Peter Sunenshine and Kevin Hirsch. The CEO is Bill Colone. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Dave Ferrera
| Società | Posizione | Fine |
|---|---|---|
Blockade Medical LLC
 Blockade Medical LLC Miscellaneous Commercial ServicesCommercial Services Blockade Medical LLC develops endovascular treatment devices for cerebral aneurysm. It offers barricade framing coil, barricade helical SR filling coil, barricade complex SR finishing coil, and electrolytic detachment system. The company was founded by Marc Tilman, Dave Ferrera, and Gibb Clark in 2011 and is headquartered in Irvine, CA. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Blockade Medical LLC
Blockade Medical LLC Miscellaneous Commercial ServicesCommercial Services Blockade Medical LLC develops endovascular treatment devices for cerebral aneurysm. It offers barricade framing coil, barricade helical SR filling coil, barricade complex SR finishing coil, and electrolytic detachment system. The company was founded by Marc Tilman, Dave Ferrera, and Gibb Clark in 2011 and is headquartered in Irvine, CA. | Commercial Services |
Singlepass, Inc.
Singlepass, Inc. Medical SpecialtiesHealth Technology Singlepass, Inc. has developed a unique electrocautery device that improves the clinical outcomes of deep tissue biopsy procedures. The company is based in Lake Forest, CA. The patented, single-use device prevents and stops bleeding caused by tissue extraction by cauterizing the tissue channel. It is the only cautery device of its kind that can be used for biopsy procedures. Singlepass was founded by Peter Sunenshine and Kevin Hirsch. The CEO is Bill Colone. | Health Technology |
- Borsa valori
- Insiders
- Dave Ferrera
